Connor Clark & Lunn Investment Management Ltd. raised its holdings in shares of Molina Healthcare, Inc. (NYSE:MOH – Get Rating) by 34.5% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 27,448 shares of the company’s stock after acquiring an additional 7,042 shares during the quarter. Connor Clark & Lunn Investment Management Ltd.’s holdings in Molina Healthcare were worth $9,064,000 as of its most recent filing with the Securities and Exchange Commission.
Several other hedge funds have also recently added to or reduced their stakes in MOH. Raymond James Financial Services Advisors Inc. grew its holdings in shares of Molina Healthcare by 5.7% during the first quarter. Raymond James Financial Services Advisors Inc. now owns 1,651 shares of the company’s stock worth $551,000 after buying an additional 89 shares in the last quarter. Allianz Asset Management GmbH grew its holdings in shares of Molina Healthcare by 496.1% during the first quarter. Allianz Asset Management GmbH now owns 11,534 shares of the company’s stock worth $3,848,000 after buying an additional 9,599 shares in the last quarter. Prudential PLC purchased a new stake in shares of Molina Healthcare during the first quarter worth about $422,000. Cetera Investment Advisers grew its holdings in shares of Molina Healthcare by 10.1% during the first quarter. Cetera Investment Advisers now owns 1,296 shares of the company’s stock worth $432,000 after buying an additional 119 shares in the last quarter. Finally, Mackay Shields LLC purchased a new stake in shares of Molina Healthcare during the first quarter worth about $2,814,000. 94.25% of the stock is currently owned by hedge funds and other institutional investors.
Analyst Upgrades and Downgrades
A number of equities research analysts have recently commented on the stock. StockNews.com downgraded shares of Molina Healthcare from a “strong-buy” rating to a “buy” rating in a report on Friday. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Molina Healthcare from $365.00 to $335.00 in a report on Monday, May 8th. Credit Suisse Group boosted their target price on shares of Molina Healthcare from $347.00 to $350.00 in a report on Friday, April 28th. Truist Financial lowered their target price on shares of Molina Healthcare from $400.00 to $380.00 and set a “buy” rating for the company in a report on Friday, February 10th. Finally, Cantor Fitzgerald began coverage on shares of Molina Healthcare in a report on Thursday, April 20th. They issued an “overweight” rating and a $354.00 target price for the company. One research analyst has rated the stock with a sell rating, four have given a hold rating and six have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $354.75.
Molina Healthcare Price Performance
Shares of MOH stock opened at $273.41 on Friday. The company has a market capitalization of $15.94 billion, a PE ratio of 18.62, a price-to-earnings-growth ratio of 1.05 and a beta of 0.68. The firm has a fifty day simple moving average of $283.82 and a 200-day simple moving average of $300.15. The company has a current ratio of 1.47, a quick ratio of 1.47 and a debt-to-equity ratio of 0.72. Molina Healthcare, Inc. has a twelve month low of $249.78 and a twelve month high of $374.00.
Molina Healthcare (NYSE:MOH – Get Rating) last announced its earnings results on Wednesday, April 26th. The company reported $5.81 earnings per share for the quarter, beating the consensus estimate of $5.13 by $0.68. The business had revenue of $8.15 billion during the quarter, compared to the consensus estimate of $8.31 billion. Molina Healthcare had a net margin of 2.64% and a return on equity of 36.20%. The business’s quarterly revenue was up 4.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $4.90 earnings per share. Equities research analysts anticipate that Molina Healthcare, Inc. will post 20.25 earnings per share for the current fiscal year.
Insider Activity
In other news, Director Daniel Cooperman sold 5,000 shares of the company’s stock in a transaction on Friday, March 3rd. The shares were sold at an average price of $276.77, for a total value of $1,383,850.00. Following the completion of the transaction, the director now directly owns 4,944 shares in the company, valued at $1,368,350.88. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 1.10% of the company’s stock.
Molina Healthcare Profile
(Get Rating)
Molina Healthcare, Inc engages in the provision of health care services. It operates through the following segments: Medicaid, Medicare, Marketplace, and Other. The company was founded by C. David Molina in 1980 and is headquartered in Long Beach, CA.
See Also
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected].
Before you consider Molina Healthcare, you’ll want to hear this.
MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Molina Healthcare wasn’t on the list.
While Molina Healthcare currently has a “Hold” rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
